Takeda Pharmaceutical Valuation
| TKDA Stock | 12.60 0.10 0.80% |
At this time, the company appears to be overvalued. Takeda Pharmaceutical has a current Real Value of USD11.43 per share. The regular price of the company is USD12.6. Our model measures the value of Takeda Pharmaceutical from inspecting the company fundamentals such as Return On Equity of 0.0477, shares outstanding of 784.48 M, and Operating Margin of 0.13 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Takeda Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Takeda Pharmaceutical is based on 3 months time horizon. Increasing Takeda Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Takeda Pharmaceutical's intrinsic value may or may not be the same as its current market price of 12.60, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.6 | Real 11.43 | Hype 12.6 |
The intrinsic value of Takeda Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Takeda Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Takeda Pharmaceutical helps investors to forecast how Takeda stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Takeda Pharmaceutical more accurately as focusing exclusively on Takeda Pharmaceutical's fundamentals will not take into account other important factors: Takeda Pharmaceutical Total Value Analysis
Takeda Pharmaceutical is at this time anticipated to have takeover price of 3.76 T with market capitalization of 39.27 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Takeda Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.76 T | 39.27 B |
Takeda Pharmaceutical Investor Information
The company had not issued any dividends in recent years. Based on the analysis of Takeda Pharmaceutical's profitability, liquidity, and operating efficiency, Takeda Pharmaceutical is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Takeda Pharmaceutical Asset Utilization
One of the ways to look at asset utilization of Takeda is to check how much profit was generated for every dollar of assets it reports. Takeda Pharmaceutical exercises its assets roughly 0.0247 %, realizing 0.0247 cents for each dollar of assets held by the company. A flourishing asset utilization indicates the company is being more effective with each dollar of assets it has. In other words, asset utilization of Takeda Pharmaceutical shows how effective it operates for each dollar spent on its assets.Takeda Pharmaceutical Ownership Allocation
Takeda Pharmaceutical shows a total of 784.48 Million outstanding shares. About 97.77 % of Takeda Pharmaceutical outstanding shares are held by general public with 2.23 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Takeda Pharmaceutical Profitability Analysis
The company reported the revenue of 3.94 T. Net Income was 230.06 B with profit before overhead, payroll, taxes, and interest of 2.44 T.About Takeda Pharmaceutical Valuation
The stock valuation mechanism determines Takeda Pharmaceutical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Takeda Pharmaceutical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Takeda Pharmaceutical. We calculate exposure to Takeda Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Takeda Pharmaceutical's related companies.8 Steps to conduct Takeda Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Takeda Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Takeda Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Takeda Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Takeda Pharmaceutical's revenue streams: Identify Takeda Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Takeda Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Takeda Pharmaceutical's growth potential: Evaluate Takeda Pharmaceutical's management, business model, and growth potential.
- Determine Takeda Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Takeda Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Takeda Stock Analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.